Helicobacter pylori: usefulness of an empirical fourth-line rifabutin-based regimen

Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures

(2012) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Empiric therapies for Helicobacter pylori infections

(2011) D. Y. Graham et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Management ofHelicobacter pyloriinfection

(2010) Francesco Costa et al.   Expert Review of Anti-Infective Therapy

One-Week Once-Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin

(2010) Stephan Miehlke et al.   HELICOBACTER

Helicobacter pyloriInfection

(2010) Kenneth E.L. McColl   NEW ENGLAND JOURNAL OF MEDICINE